Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding.

Expert opinion on drug metabolism & toxicology - 1 Apr 2020

Macías Yolanda, Gómez Tabales Javier, García-Martín Elena, Agúndez José A G

Abstract excerpt

Introduction: Several reports suggest a possible association between polymorphisms in the cytochrome P450 2C9 (CYP2C9) gene and the risk for non-steroidal anti-inflammatory drug (NSAID)-related adverse gastrointestinal events, including gastrointestinal bleeding. Because findings were controversial, a systematic review and a meta-analysis of eligible studies on this putative association was conducted.Areas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents, Non-Steroidal
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Diseases

Share to Gastrointestinal Hemorrhage

Share to Genotype

Share to Inflammatory mediators and NSAID effects

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Source

Identifiers

PMID: 32187502
DOI: 10.1080/17425255.2020.1744563

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding.PMID 32187502Read ↗

Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.Semantic proximity Read ↗

CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleedingSemantic proximity Read ↗

Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?Semantic proximity Read ↗

Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.Semantic proximity Read ↗

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use.Semantic proximity Read ↗

Clinical and pharmacogenetic features of patients with upper gastrointestinal lesions at a multidisciplinary hospital: the role of nonsteroidal anti-inflammatory drugs.Semantic proximity Read ↗

Allele variants of the cytochrome P450 2C9 genotype in white subjects from The Netherlands with serious gastroduodenal ulcers attributable to the use of NSAIDs.Semantic proximity Read ↗

No modification of the beneficial effect of NSAIDs on colorectal cancer by CYP2C9 genotype.Semantic proximity Read ↗

Pharmacogenomics of non-steroidal antiinflammatory drug-induced gastrointestinal complicationsSemantic proximity Read ↗

Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review.Semantic proximity Read ↗

CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.